2016
DOI: 10.1159/000442463
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of Notch Signaling Ameliorates Acute Kidney Failure and Downregulates Platelet-Derived Growth Factor Receptor β in the Mouse Model

Abstract: Ischemic acute kidney injury (AKI) is associated with high morbidity and frequent complications. Repeated episodes of AKI may lead to end-stage renal failure. The pathobiology of regeneration in AKI is not well understood and there is no effective clinical therapy that improves regeneration. The Notch signaling pathway plays an essential role in kidney development and has been implicated in tissue repair in the adult kidney. Here, we found that kidneys after experimental AKI in mice showed increased expression… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(5 citation statements)
references
References 38 publications
0
5
0
Order By: Relevance
“…Blockade of the Notch pathway, by using γ-secretase inhibitor starting at 24h and at 1-2 hrs before ischemia-reperfusion injury, involved less interstitial edema formation, a decreased expression of the Notch receptors (Notch3 and Notch1), its ligands (Delta-like-4 and Jagged-1) and PDGFB leading to a reduction of fibrosis with an amelioration of renal function. These data demonstrate that the severity of kidney injury can be ameliorated by blocking Notch activation through pharmacologic inhibition of Notch activation following AKI [88] ( Figure 2). [89].…”
Section: Hippo and Notch Signaling Pathwaysmentioning
confidence: 72%
“…Blockade of the Notch pathway, by using γ-secretase inhibitor starting at 24h and at 1-2 hrs before ischemia-reperfusion injury, involved less interstitial edema formation, a decreased expression of the Notch receptors (Notch3 and Notch1), its ligands (Delta-like-4 and Jagged-1) and PDGFB leading to a reduction of fibrosis with an amelioration of renal function. These data demonstrate that the severity of kidney injury can be ameliorated by blocking Notch activation through pharmacologic inhibition of Notch activation following AKI [88] ( Figure 2). [89].…”
Section: Hippo and Notch Signaling Pathwaysmentioning
confidence: 72%
“…The Notch family consists of a group of highly conserved proteins including four cognate receptor Notch l-4, 5 types of homolog ligand Delta-like 1, 3 and 4, and Jagged 1 and 2, and two types of downstream target genes: The Hes and Hey families. When tissue is subjected to hypoxia and drug damage, the activation of ligand expression would increase, which can result in the series of proteolytic cleavage of Notch receptors via the Notch receptor binding through cell to cell contact, and then release the Notch intracellular domain of activity; the Notch intracellular domain activity is transferred to the cell nucleus and combined with the transcription factor binding, starting the transcription of the target gene, regulating and controlling the cell proliferation (7,8). …”
Section: Discussionmentioning
confidence: 99%
“…Western blotting was performed as described elsewhere (7). The primary antibody was used for incubation overnight at 4°C.…”
Section: Methodsmentioning
confidence: 99%
“…In the BMP9 group, OS was induced, and BMP9 overexpressing ADMSCs were injected into the articular cavity. In the LY group, OS was induced, and LY411575 (1.5 µmol/l) ( 28 , 29 ) was injected into the articular cavity to inhibit the Notch signaling pathway, and BMP9 overexpressing ADMSCs were also injected.…”
Section: Methodsmentioning
confidence: 99%